Volume 3, Issue 12 (1-2014)                   NCMBJ 2014, 3(12): 107-110 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Hasanvand Jamadi1 R, Asadi A, Hasanvand Jamadi M. In vitro evaluation of anticancer activity of brevinin-2R against AGS cell line. NCMBJ 2014; 3 (12) :107-110
URL: http://ncmbjpiau.ir/article-1-458-en.html
-Department of biology, Faculty of science, Mohaghegh Ardabili University, Ardabil, Iran , Robab.hasanvand@yahoo.com
Abstract:   (16122 Views)

Background & aim: Gastro-intestinal cancers are the most common kind of cancers all over the world. They are multifactorial disease and both genetical and environmental factors are involved in their progression. Adenocarcinoma is the most common type of stomach cancers. Brevinin-2R is a novel antimicrobial and anticancer peptide that is isolated from the skin secretions of a family of frogs called Rana. The 25-amino acid long peptide shows anticancer activity and induces antimicrobial activity. Brevinin-2R is a 25 amino acid long cationic peptide that shows very low hemolytic activity against red blood cells. In this paper we study cytotoxicity of brevinin-2R onto AGS cell line.

Material and Methods: AGS cell line incubated with different concentrations of peptide and different period of time, cytotoxicity of peptide and viability of AGS cell line assessed by MTT-assay. The experiment repeated three times and the average viability values were calculated.

Results: Findings shows that viability of treated cells decreased consistent with increasing concentrations and period of time.

Conclusion: Because of low hemolytic activity, Brevinin-2R is a good specimen in drug designing. Brevinin-2R triggers cell death by means of activation of autophagy and shows anticancer activity against AGS malignant cell lines.

Full-Text [PDF 334 kb]   (3206 Downloads)    
Type of Study: Research Article | Subject: Physiology
Received: 2014/02/19 | Accepted: 2014/02/19 | Published: 2014/02/19

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | New Cellular and Molecular Biotechnology Journal

Designed & Developed by : Yektaweb